Advertisement
Screener

Theravance Biopharma, Inc. (TBPH) Increase (Decrease) in Other Noncurrent Liabilities

Theravance Biopharma, Inc. Increase (Decrease) in Other Noncurrent Liabilities

Theravance Biopharma, Inc. (TBPH) reported Increase (Decrease) in Other Noncurrent Liabilities of -$69.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-11

  • Theravance Biopharma, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
  • Theravance Biopharma, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was -$69.00K, a 201.47% decline year-over-year.
  • Theravance Biopharma, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was -$1.00K.
  • Theravance Biopharma, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was -$1.00K, a 125.00% decline year-over-year.
  • Theravance Biopharma, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2025 was $67.00K.
  • Theravance Biopharma, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2024 was -$532.00K, a 107.05% decline from fiscal 2023.
  • Theravance Biopharma, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2023 was $7.55M.
  • Theravance Biopharma, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$525.00K, a 167.57% decline from fiscal 2021.
Period endIncrease (Decrease) in Other Noncurrent Liabilities 3 monthIncrease (Decrease) in Other Noncurrent Liabilities 6 monthIncrease (Decrease) in Other Noncurrent Liabilities 9 monthIncrease (Decrease) in Other Noncurrent Liabilities 12 monthIncrease (Decrease) in Other Noncurrent Liabilities 12 month as first filed
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
-$69.00K
10-Q · filed 2026-08-11
-$70.00K
derived: sum of 3 quarters · filed 2026-08-11
-$71.00K
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31-$69.00K
10-Q · filed 2026-05-07
-$70.00K
derived: sum of 2 quarters · filed 2026-05-07
-$71.00K
derived: sum of 3 quarters · filed 2026-05-07
-$70.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23
-$2.00K
derived: sum of 2 quarters · filed 2026-03-23
-$1.00K
derived: sum of 3 quarters · filed 2026-08-11
$67.00K
10-K · filed 2026-03-23
2025-09-30-$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$0.00
derived: sum of 2 quarters · filed 2026-08-11
$68.00K
10-Q · filed 2025-11-12
-$507.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-06-30$1.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
$69.00K
10-Q · filed 2026-08-11
-$506.00K
derived: sum of 3 quarters · filed 2026-08-11
-$502.00K
derived: sum of 4 quarters · filed 2026-08-11
2025-03-31$68.00K
10-Q · filed 2026-05-07
-$507.00K
derived: sum of 2 quarters · filed 2026-05-07
-$503.00K
derived: sum of 3 quarters · filed 2026-05-07
-$503.00K
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$575.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23
-$571.00K
derived: sum of 2 quarters · filed 2026-03-23
-$571.00K
derived: sum of 3 quarters · filed 2026-03-23
-$532.00K
10-K · filed 2026-03-23
2024-09-30$4.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$4.00K
derived: sum of 2 quarters · filed 2025-11-12
$43.00K
10-Q · filed 2025-11-12
$6.29M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
$39.00K
10-Q · filed 2025-08-13
$6.29M
derived: sum of 3 quarters · filed 2025-08-13
$7.26M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$39.00K
10-Q · filed 2025-05-12
$6.29M
derived: sum of 2 quarters · filed 2025-05-12
$7.26M
derived: sum of 3 quarters · filed 2025-05-12
$8.05M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31$6.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07
$7.22M
derived: sum of 2 quarters · filed 2025-03-07
$8.02M
derived: sum of 3 quarters · filed 2025-03-07
$7.55M
10-K · filed 2025-03-07
2023-09-30$969.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$1.76M
derived: sum of 2 quarters · filed 2024-11-14
$1.29M
10-Q · filed 2024-11-14
$1.19M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$794.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$326.00K
10-Q · filed 2024-08-08
$222.00K
derived: sum of 3 quarters · filed 2024-08-08
-$182.00K
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$468.00K
10-Q · filed 2024-05-15
-$572.00K
derived: sum of 2 quarters · filed 2024-05-15
-$976.00K
derived: sum of 3 quarters · filed 2024-05-15
-$1.00M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$104.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01
-$508.00K
derived: sum of 2 quarters · filed 2024-03-01
-$533.00K
derived: sum of 3 quarters · filed 2024-03-01
-$525.00K
10-K · filed 2024-03-01
2022-09-30-$404.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$429.00K
derived: sum of 2 quarters · filed 2023-11-09
-$421.00K
10-Q · filed 2023-11-09
-$420.00K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30-$25.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$17.00K
10-Q · filed 2023-08-09
-$16.00K
derived: sum of 3 quarters · filed 2023-08-09
2022-03-31$8.00K
10-Q · filed 2023-05-10
$9.00K
derived: sum of 2 quarters · filed 2023-05-10
2021-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$777.00K
10-K · filed 2023-03-01
$587.00K
10-K · filed 2022-02-28
2021-09-30$776.00K
10-Q · filed 2022-11-09
2021-03-31$224.00K
10-Q · filed 2022-05-06
$895.00K
derived: sum of 2 quarters · filed 2023-03-01
$985.00K
derived: sum of 3 quarters · filed 2023-03-01
$1.02M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$671.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$761.00K
derived: sum of 2 quarters · filed 2023-03-01
$792.00K
derived: sum of 3 quarters · filed 2023-03-01
$936.00K
10-K · filed 2023-03-01
-$7.61M
10-K · filed 2021-02-26
2020-09-30$90.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
$121.00K
derived: sum of 2 quarters · filed 2021-11-08
$265.00K
10-Q · filed 2021-11-08
$805.00K
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$31.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$175.00K
10-Q · filed 2021-08-05
$715.00K
derived: sum of 3 quarters · filed 2022-02-28
-$4.84M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$144.00K
10-Q · filed 2021-05-06
$684.00K
derived: sum of 2 quarters · filed 2022-02-28
-$4.87M
derived: sum of 3 quarters · filed 2022-02-28
-$4.68M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$540.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
-$5.02M
derived: sum of 2 quarters · filed 2022-02-28
-$4.82M
derived: sum of 3 quarters · filed 2022-02-28
-$4.75M
10-K · filed 2022-02-28
2019-09-30-$5.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
-$5.36M
derived: sum of 2 quarters · filed 2020-11-09
-$5.29M
10-Q · filed 2020-11-09
-$10.20M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$196.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$269.00K
10-Q · filed 2020-08-10
-$4.64M
derived: sum of 3 quarters · filed 2021-02-26
-$4.64M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$73.00K
10-Q · filed 2020-05-08
-$4.84M
derived: sum of 2 quarters · filed 2021-02-26
-$4.84M
derived: sum of 3 quarters · filed 2021-02-26
-$11.25M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31-$4.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
-$4.91M
derived: sum of 2 quarters · filed 2021-02-26
-$11.32M
derived: sum of 3 quarters · filed 2021-02-26
-$10.06M
10-K · filed 2021-02-26
2018-09-30-$3.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$6.41M
derived: sum of 2 quarters · filed 2019-11-08
-$5.15M
10-Q · filed 2019-11-08
$5.96M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30-$6.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05
-$5.14M
10-Q · filed 2019-08-05
$5.96M
derived: sum of 3 quarters · filed 2020-02-27
$13.45M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$1.27M
10-Q · filed 2019-05-10
$12.38M
derived: sum of 2 quarters · filed 2020-02-27
$19.86M
derived: sum of 3 quarters · filed 2020-02-27
$20.36M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$11.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$18.59M
derived: sum of 2 quarters · filed 2020-02-27
$19.09M
derived: sum of 3 quarters · filed 2020-02-27
$24.45M
10-K · filed 2020-02-27
2017-09-30$7.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$7.99M
derived: sum of 2 quarters · filed 2018-11-08
$13.34M
10-Q · filed 2018-11-08
$17.57M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$505.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$5.86M
10-Q · filed 2018-08-02
$10.09M
derived: sum of 3 quarters · filed 2019-02-28
$15.04M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$5.35M
10-Q · filed 2018-05-09
$9.59M
derived: sum of 2 quarters · filed 2019-02-28
$14.54M
derived: sum of 3 quarters · filed 2019-02-28
$14.45M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$4.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$9.18M
derived: sum of 2 quarters · filed 2019-02-28
$9.10M
derived: sum of 3 quarters · filed 2019-02-28
$9.69M
10-K · filed 2019-02-28
2016-09-30$4.95M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$4.87M
derived: sum of 2 quarters · filed 2017-11-08
$5.46M
10-Q · filed 2017-11-08
$6.54M
derived: sum of 4 quarters · filed 2018-02-28
2016-06-30-$82.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$508.00K
10-Q · filed 2017-08-09
$1.59M
derived: sum of 3 quarters · filed 2018-02-28
$949.00K
derived: sum of 4 quarters · filed 2018-02-28
2016-03-31$590.00K
10-Q · filed 2017-05-10
$1.67M
derived: sum of 2 quarters · filed 2018-02-28
$1.03M
derived: sum of 3 quarters · filed 2018-02-28
$1.43M
derived: sum of 4 quarters · filed 2018-02-28
2015-12-31$1.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
$441.00K
derived: sum of 2 quarters · filed 2018-02-28
$843.00K
derived: sum of 3 quarters · filed 2018-02-28
$1.16M
10-K · filed 2018-02-28
2015-09-30-$640.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$238.00K
derived: sum of 2 quarters · filed 2016-11-09
$83.00K
10-Q · filed 2016-11-09
$949.00K
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$402.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$723.00K
10-Q · filed 2016-08-09
$1.59M
derived: sum of 3 quarters · filed 2017-03-01
$1.59M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31$321.00K
10-Q · filed 2016-05-10
$1.19M
derived: sum of 2 quarters · filed 2017-03-01
$1.19M
derived: sum of 3 quarters · filed 2017-03-01
$1.19M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31$866.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$866.00K
derived: sum of 2 quarters · filed 2017-03-01
$866.00K
derived: sum of 3 quarters · filed 2017-03-01
$866.00K
10-K · filed 2017-03-01
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
$0.00
derived: sum of 2 quarters · filed 2015-11-12
$0.00
10-Q · filed 2015-11-12
2014-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
$0.00
10-Q · filed 2015-08-13
2014-03-31$0.00
10-Q · filed 2015-05-13
2013-12-31$0.00
10-K · filed 2016-03-11
2012-12-31$0.00
10-K · filed 2015-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cryoport, Inc. (CYRX)United States$0.881B-21.29
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Apnimed, Inc. (APMD)United States$0.899B
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71